Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CI
CI logo

CI Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
268.880
Open
266.550
VWAP
267.28
Vol
576.12K
Mkt Cap
70.33B
Low
265.450
Amount
153.98M
EV/EBITDA(TTM)
7.05
Total Shares
263.66M
EV
93.22B
EV/OCF(TTM)
9.71
P/S(TTM)
0.26
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
Show More

Events Timeline

(ET)
2026-03-26
14:10:00
U.S. Justice Department Sues New York-Presbyterian Hospital for Antitrust Violations
select
link
2026-03-12 (ET)
2026-03-12
16:20:00
Major Averages Drop Over 1% Amid Iran War
select
2026-03-12
12:00:00
Markets Volatile Amid Iran War, Oil Prices Surge Over 10%
select
2026-03-03 (ET)
2026-03-03
16:20:00
US Stocks Drop Amid Middle East Tensions; Trump Announces Maritime Trade Security Measures
select
2026-03-03
11:50:00
Middle East Conflict Escalates, Major Indices Down Nearly 1.5%
select
2026-03-03
10:30:00
JPMorgan Maintains Overweight Rating on Cigna
select
2026-03-03
10:20:00
Barclays Calls Cigna's New CEO Evanko a Natural Successor
select

News

CNBC
8.5
16:03 PMCNBC
Eli Lilly's GLP-1 Pill Approval Marks New Weight Loss Market Entry
  • Regulatory Milestone: The FDA's approval of Eli Lilly's GLP-1 pill, Foundayo, represents a significant advancement for the company in the weight-loss medication market, setting the stage for competition with Novo Nordisk's Wegovy and altering market dynamics.
  • Pricing Strategy: Foundayo is priced at $25 per month with insurance or between $149 and $349 out-of-pocket, aiming to attract a broader patient base, particularly appealing to seniors, thereby expanding the market for weight-loss drugs.
  • Global Market Expansion: Lilly plans to seek approval for Foundayo in over 40 countries within the next year, leveraging its small molecule nature to enable global production and distribution without cold-chain constraints, enhancing its competitive edge.
  • Sales Projections: Analysts estimate Foundayo's sales could reach $14.79 billion by 2030, although lower than Zepbound's $24.68 billion, it still indicates strong market potential and is seen as a key factor for Eli Lilly's stock recovery.
stocktwits
7.0
03-25stocktwits
CVS Health Reaches Proposed Settlement with FTC on Insulin Pricing
  • Settlement Progress: CVS Health's proposed settlement with the FTC is expected to be finalized in the coming weeks, modeled after a similar agreement with Cigna's Express Scripts, indicating the company's proactive stance on drug pricing transparency.
  • Stock Price Reaction: Following the settlement news, CVS Health shares rose 2% on Tuesday, reflecting market optimism about the agreement, with analysts suggesting that this resolution will alleviate uncertainties in the pharmacy benefit management sector, thereby boosting investor confidence.
  • Market Outlook: Leerink reiterated an 'Outperform' rating on CVS Health with a $98 price target, suggesting a potential upside of approximately 35% from Tuesday's closing price, indicating a positive market sentiment regarding the company's future performance.
  • Cost Reduction for Patients: The settlement with the FTC is expected to lower patients' out-of-pocket costs for insulin and other drugs by up to $7 billion over the next decade, highlighting CVS's strategic importance in advocating for drug price rationalization.
Newsfilter
8.5
03-24Newsfilter
Cigna Foundation Supports Veteran Housing Initiatives
  • Funding Support: The Cigna Foundation invested over $3 million across 10 states, enabling 22 nonprofit partners to provide stable housing and integrated support services to 8,000 veterans, significantly improving their quality of life.
  • Housing Solutions: By delivering 128 stable housing solutions and 116 housing modifications, nonprofit partners assisted 989 veterans in securing permanent or transitional housing, alleviating mental health stress associated with housing instability.
  • Employee Volunteerism: In 2025, over 200 Cigna employees volunteered more than 1,000 hours, engaging in home building and creating care packages, which enhanced community support for veterans and demonstrated corporate social responsibility.
  • Long-term Commitment: The Cigna Foundation's three-year, $27 million commitment focuses on improving veteran mental health and housing stability, reflecting the company's dedication to social responsibility and ongoing support for the veteran community.
PRnewswire
8.5
03-24PRnewswire
Cigna Group Foundation Releases Veteran Mental Health Impact Report
  • Investment and Impact: The Cigna Group Foundation invested over $3 million across 10 states, supporting 22 nonprofit partners to assist 8,000 veterans in gaining stable housing and integrated support services, significantly improving veterans' quality of life.
  • Housing Stability Improvement: By providing 12 new homes and 116 housing modifications, nearly all veterans receiving housing assistance experienced positive life changes, indicating the program's effectiveness in addressing housing instability.
  • Employee Volunteerism: In 2025, over 200 employee volunteers contributed more than 1,000 hours to support local nonprofits, showcasing the company's commitment to enhancing veteran mental health through community engagement and social responsibility.
  • Long-term Commitment: The Cigna Group Foundation has pledged $27 million over three years to improve veteran mental health, with $9 million specifically allocated to enhancing veterans' mental wellbeing through housing stability, reflecting the company's ongoing dedication to social responsibility.
CNBC
8.0
03-19CNBC
Americans Drop Health Insurance Coverage as Premiums Surge
  • Decline in Coverage: A KFF survey reveals that approximately 9% of ACA marketplace enrollees lost their insurance after the expiration of subsidies, indicating a direct impact of rising premiums that may lead to more individuals facing healthcare cost burdens.
  • Significant Premium Increases: With the lapse of enhanced premium tax credits, average premiums for ACA enrollees are expected to double by 2026, exacerbating financial pressures on households and affecting their spending capabilities.
  • Voter Sentiment Shift: The survey indicates that 54% of returning ACA enrollees blame rising healthcare costs on congressional Republicans and Trump, suggesting that healthcare affordability could become a pivotal political issue in the upcoming midterm elections, influencing voter turnout.
  • Household Financial Strain: About 55% of ACA enrollees report cutting back on essential expenses like food and clothing to afford healthcare costs, highlighting the profound impact of medical expenses on household finances, which could lead to higher unemployment rates and economic instability.
moomoo
4.0
03-13moomoo
CIGNA: Bernstein Upgrades to Outperform from Market Perform; Increases Target Price to $358 from $307
  • Company Performance: Cigna has reported an increase in market performance, indicating a positive trend in its financial health.

  • Target Price Adjustment: The target price for Cigna's stock has been raised to $358 from a previous $307, reflecting increased investor confidence.

Wall Street analysts forecast CI stock price to rise
16 Analyst Rating
Wall Street analysts forecast CI stock price to rise
14 Buy
2 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
300.00
Averages
335.63
High
378.00
Current: 0.000
sliders
Low
300.00
Averages
335.63
High
378.00
Bernstein
Market Perform -> Outperform
upgrade
$358
AI Analysis
2026-03-12
Reason
Bernstein
Price Target
$358
AI Analysis
2026-03-12
upgrade
Market Perform -> Outperform
Reason
Bernstein upgraded Cigna to Outperform from Market Perform with a $358 price target.
Bernstein
Market Perform -> Outperform
upgrade
$307 -> $358
2026-03-12
Reason
Bernstein
Price Target
$307 -> $358
2026-03-12
upgrade
Market Perform -> Outperform
Reason
As previously reported, Bernstein upgraded Cigna to Outperform from Market Perform with a price target of $358, up from $307. The firm sees the combination of the Pharmacy Benefit Manager reform bill and the FTC settlement, coupled with the already announced PBM model changes and economic impacts that Cigna has detailed, as "clearing events" that will increase the multiple over time, the analyst tells investors. The firm is updating its earnings model with EPS estimates roughly the same for 2026 and "modestly higher" for 2027-2030, the analyst added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CI
Unlock Now

Valuation Metrics

The current forward P/E ratio for Cigna Group (CI.N) is 9.02, compared to its 5-year average forward P/E of 10.78. For a more detailed relative valuation and DCF analysis to assess Cigna Group's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
10.78
Current PE
9.02
Overvalued PE
11.94
Undervalued PE
9.62

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
8.94
Current EV/EBITDA
7.27
Overvalued EV/EBITDA
9.82
Undervalued EV/EBITDA
8.05

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.39
Current PS
0.24
Overvalued PS
0.47
Undervalued PS
0.32

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

top stocks in health sector
Intellectia · 38 candidates
Market Cap: >= 10.00BSector: Healthcare, Healthcare Services & EquipmentIndustry: Biotechnology & Medical Research, Healthcare Equipment & Supplies, Healthcare Providers & Services, PharmaceuticalsAnalyst Consensus: Strong Buy, Moderate BuyRevenue 5yr Cagr: >= 5List Exchange: XNYS, XNAS, XASEReturn On Equity: >= 10.0%
Ticker
Name
Market Cap$
top bottom
LLY logo
LLY
Eli Lilly and Co
866.87B
ABBV logo
ABBV
AbbVie Inc
364.65B
AZN logo
AZN
AstraZeneca PLC
293.00B
MRK logo
MRK
Merck & Co Inc
282.35B
UNH logo
UNH
UnitedHealth Group Inc
254.55B
AMGN logo
AMGN
Amgen Inc
188.63B
give me a selection of long term stocks
Intellectia · 27 candidates
Market Cap: >= 50.00BRevenue 5yr Cagr: >= 8Pe Ttm: 12 - 30Return On Equity: >= 13.0%Is Index Component: GSPC
Ticker
Name
Market Cap$
top bottom
META logo
META
Meta Platforms Inc
1.66T
JPM logo
JPM
JPMorgan Chase & Co
775.45B
MU logo
MU
Micron Technology Inc
471.24B
MRK logo
MRK
Merck & Co Inc
287.32B
MS logo
MS
Morgan Stanley
255.47B
GS logo
GS
Goldman Sachs Group Inc
244.45B
name me one concrete stock to buy
Intellectia · 28 candidates
Market Cap: >= 10.00BRegion: USQuarter Revenue Yoy Growth: >= 10.0%Pe Ttm: 10 - 30List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Is Index Component: GSPCOne Month Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
DE logo
DE
Deere & Co
163.44B
FE logo
FE
FirstEnergy Corp
28.94B
CTRA logo
CTRA
Coterra Energy Inc
23.80B
MPWR logo
MPWR
Monolithic Power Systems Inc
57.06B
PKG logo
PKG
Packaging Corp of America
22.16B
HUBB logo
HUBB
Hubbell Inc
27.86B
stocks to look into tmr
Intellectia · 9 candidates
Relative Vol: >= 2Is Index Component: GSPCOne Day Rise Prob: >= 55Monthly Average Dollar Volume: >= 5,000,000
Ticker
Name
Market Cap$
top bottom
WAB logo
WAB
Westinghouse Air Brake Technologies Corp
41.66B
ROK logo
ROK
Rockwell Automation Inc
47.41B
EBAY logo
EBAY
eBay Inc
39.08B
IR logo
IR
Ingersoll Rand Inc
38.97B
KKR logo
KKR
KKR & Co Inc
91.54B
EXPE logo
EXPE
Expedia Group Inc
28.41B
which stocks should I buy?
Intellectia · 68 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 2Beta: LowRisk, ModerateRiskRevenue 5yr Cagr: >= 5Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
NVO logo
NVO
Novo Nordisk A/S
263.42B
RY logo
RY
Royal Bank of Canada
235.24B
GILD logo
GILD
Gilead Sciences Inc
160.18B
Can you add a screener for me?A I
Intellectia · 69 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 2Revenue 5yr Cagr: >= 5Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
NVO logo
NVO
Novo Nordisk A/S
263.42B
RY logo
RY
Royal Bank of Canada
235.24B
GILD logo
GILD
Gilead Sciences Inc
160.18B
insiders buying in last 30 days
Intellectia · 505 candidates
Insider Transactions: NetPurchase
Ticker
Name
Market Cap$
top bottom
GE logo
GE
General Electric Co
335.96B
LIN logo
LIN
Linde PLC
205.15B
SPGI logo
SPGI
S&P Global Inc
160.84B
ETN logo
ETN
Eaton Corporation PLC
131.26B
SBUX logo
SBUX
Starbucks Corp
109.65B
NKE logo
NKE
Nike Inc
96.83B
select 5 stocks with strong buy rating
Intellectia · 90 candidates
Market Cap: >= 10.00BAnalyst Consensus: Strong BuyPe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
BAC logo
BAC
Bank of America Corp
375.55B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
RY logo
RY
Royal Bank of Canada
235.24B
ABT logo
ABT
Abbott Laboratories
209.93B
DIS logo
DIS
Walt Disney Co
202.08B
C logo
C
Citigroup Inc
198.97B
¿Qué acción debería invertir sí o si
Intellectia · 69 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 2Revenue 5yr Cagr: >= 5Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
NVO logo
NVO
Novo Nordisk A/S
263.42B
RY logo
RY
Royal Bank of Canada
235.24B
GILD logo
GILD
Gilead Sciences Inc
160.18B
what is a good thing to in vest in now
Intellectia · 69 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 2Revenue 5yr Cagr: >= 5Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
NVO logo
NVO
Novo Nordisk A/S
263.42B
RY logo
RY
Royal Bank of Canada
235.24B
GILD logo
GILD
Gilead Sciences Inc
160.18B

Whales Holding CI

M
Mubadala Investment Company PJSC
Holding
CI
+19.49%
3M Return
G
GQG Partners, LLC
Holding
CI
+13.93%
3M Return
S
SAMA Foreign Holdings
Holding
CI
+9.52%
3M Return
C
Conning, Inc.
Holding
CI
+8.66%
3M Return
G
Greenlight Capital, Inc.
Holding
CI
+3.21%
3M Return
D
Distillate Capital Partners LLC
Holding
CI
+2.43%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Cigna Group (CI) stock price today?

The current price of CI is 267.5 USD — it has increased 0.28

What is Cigna Group (CI)'s business?

The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.

What is the price predicton of CI Stock?

Wall Street analysts forecast CI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CI is335.63 USD with a low forecast of 300.00 USD and a high forecast of 378.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Cigna Group (CI)'s revenue for the last quarter?

Cigna Group revenue for the last quarter amounts to 72.47B USD, increased 10.39

What is Cigna Group (CI)'s earnings per share (EPS) for the last quarter?

Cigna Group. EPS for the last quarter amounts to 4.55 USD, decreased -11.31

How many employees does Cigna Group (CI). have?

Cigna Group (CI) has 67700 emplpoyees as of April 01 2026.

What is Cigna Group (CI) market cap?

Today CI has the market capitalization of 70.33B USD.